About ▼ Careers Internship MedBlog Contact us

LOGIN REGISTER

Medindia » News » Drug News » Indian Pharma Company, Dr Reddy’s, Introduces BP Tablets in US Market

Indian Pharma Company, Dr Reddy’s, Introduces BP Tablets in US Market

by Savitha C Muppala on Sep 13 2012 8:02 PM

Indian Pharma Company, Dr Reddy’s, Introduces BP Tablets in US Market

On September 11^th, Dr Reddy’s Laboratories, the Hyderabad based pharmaceutical company introduced Metoprolol Succinate ER (Extended-Release) tablets in 25 mg, 50 mg, 100 mg & 200 mg dosages, in the US market.

According to the communication from Dr Reddy’s laboratories, Metoprolol ER tablets, used to treat high blood pressure, had received the approval from the United States Food & Drug Administration (USFDA) in August this year.

Congestive Heart Failure (Congestive Cardiac Failure) Current Management

Congestive Heart Failure (Congestive Cardiac Failure) Current Management
Congestive heart failure (CHF) is a condition in which the heart fails to work adequately as a pump that can deliver oxygen rich blood to the body.

Source-Medindia

Importance of Rural India vis-a-vis Indian Healthcare Reforms

Importance of Rural India vis-a-vis Indian Healthcare Reforms
An insight into the currently prevailing scenario pertaining to healthcare sector across India with special focus on the rural masses.

Low Blood Pressure | Hypotension

Low Blood Pressure | Hypotension
If your blood pressure is persistently less than 90/60 mm Hg you are suffering from Low blood pressure or Hypotension.

Recommended Readings

Fruits to Help Lower Blood Pressure

Fruits to Help Lower Blood Pressure

Top reasons why you should eat fruits to lower blood pressure and reduce the risk of heart disease. Antioxidants in fruits keep your blood pressure under control.

Drug Toxicity

Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a drug, reaction to a drug or drug abuse.

Latest Drug News

US FDA Approval of N-803: Ray of Hope For Bladder Cancer Patients

US FDA Approval of N-803: Ray of Hope For Bladder Cancer Patients

The US FDA approves a immunotherapy drug, N-803, for BCG-unresponsive non-muscle invasive bladder cancer, suggested to be used in conjunction with BCG.

Resmetirom For MASH: Approved by US FDA, Increase in Partnerships

Resmetirom For MASH: Approved by US FDA, Increase in Partnerships

The increasing trend in strategic partnerships between innovator companies, and the US FDA approval for Rezdiffra has led to a boost in the development of medications for MASH.

Semaglutide: A Dominant Player for Patients With Heart Failure

Semaglutide: A Dominant Player for Patients With Heart Failure

Data provesSemaglutideefficacy in treatment of Type 2 diabetes, obesity, heart failure, and chronic kidney failure, it emerges as important therapy in metabolic syndrome.

Physician's Lack Agreement – Patients Prefer Branded or Generic Drugs?

Physician's Lack Agreement – Patients Prefer Branded or Generic Drugs?

Generics are not widely used, despite cost advantage, due to a lack of information to patients and reluctance from physicians to prescribe generics - A Need to educate masses

Drug Resistant Melanoma Caused Due to Break in Genes!

Drug Resistant Melanoma Caused Due to Break in Genes!

Studies have led to discovery that drug-resistant melanomas are caused by breaks in the genes, thereby leading to emphasis on alternate targeted therapies to combat cancer.

Advertisement